Recurrent respiratory papillomatosis

Archives of Disease in Childhood

Volumn 91, Issue 8, 2006, Pages 689-691

  Tasca, R A ^a   Clarke, R W ^b  

^a LEIGHTON HOSPITAL   (United Kingdom)

^b ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ACICLOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; CIDOFOVIR; HEAT SHOCK PROTEIN 65; HYBRID PROTEIN; MUMPS VACCINE; PROTEIN E7;

ADJUVANT THERAPY; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; INCIDENCE; MINIMAL RESIDUAL DISEASE; MULTIPLE CANCER; PAPILLOMATOSIS; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY SYSTEM; REVIEW; TRACHEOTOMY; WART VIRUS;

ANTIVIRAL AGENTS; CHILD; EARLY DIAGNOSIS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; RESPIRATORY TRACT NEOPLASMS; TRACHEOTOMY;

EID: 33746874455     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.090514     Document Type: Review

References (31)

1. Morgan AH, Zitch RP. Recurrent respiratory papillomatosis in children: a retrospective study of management and complications. Ear Nose Throat J 1986;65:19-28.
2. Derltay CS. Task force on recurrent respiratory papillomas: a preliminary report. Arch Otolaryngol Head Neck Surg 1995;121:1386-91.
3. Rabah R, Lancaster WD, Thomas R, et al. Human papillomavirus-11- associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 2001;4:68-72.
4. Kashima HK, Shah F, Lyles A, et al. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 1992;102:9-13.
5. Shah K, Kashima HK, Polk BF, et al. Rarity of caesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol 1986;68:795-9.
6. Tenti P, Zappatore R, Migliora P, et al. Perinatal transmission of human papillomavirus from gravidas with latent infection. Obstet Gynecol 1999;93:475-9.
7. Kosko JR, Derkay CS. Role of cesarean section in prevention of recurrent respiratory papillomatosis - is there one? Int J Pediatr Otorhinolaryngol 1996;35:31-8.
8. Wiatrak BJ, Wiatrak DW, Broker TR, et al. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 2004;114(11, pt 2, suppl 104):1-23.
9. Reidy PM, Dedo HH, Rabah R, et al. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 2004;114:1906-9.
10. Armstrong LR, Derkay CS, Reeves WC. Initial results from the National Registry for Juvenile-Onset Recurrent Respiratory Papillomatosis. Arch Otolaryngol Head Neck Surg 1999;125:743-8.
11. Healy GB, Gelber RD, Trowbridge AL, et al. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical study. N Engl J Med 1988;319:401-7.
12. Leventhal BG, Kashima HK, Week PW, et al. Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis. Arch Otolaryngol Head Neck Surg 1988;114:1163-9.
13. Nodarse-Cuni H, Iznaga-Marin N, Viera-Alvarez D, et al. Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report). J Laryngol Otol 2004;118:681-7.
14. Shehab N, Sweet B, Hogikyan ND, et al. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. Pharmacotherapy 2005;25:977-89.
15. Pransky SM, Albright JT, Magit AE. Long term follow up of paediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 2003;113:1583-7.
16. Milczuk HA. Intralesional cidofovir for the treatment of juvenile recurrent respiratory papillomatosis: long term follow up of 4 children. Otohryngol Head Neck Surg 2003;128:788-94.
17. Akst LM, Lee W, Discolo C, et al. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 2003;129:841-6.
18. Lee AS, Rosen CA. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis. J Voice 2004;18:551-6.
19. Shirley WP, Wiatrak B. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children? Int J Pediatr Otolarhinolaryngol 2004;68:413-18.
20. Mandell DL, Armjand EM, Kay DJ, et al. Intralesional cidofovir for pediatric respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2004;130:1319-23.
21. Naiman AN, Ceruse P, Coulombeau B, et al. Intralesional cidofovir and surgical excision for laryngeal papillomatosis. Laryngoscope 2003;113:2174-81.
22. Derkay CS. Cidofovir for recurrent respiratory papillomatosis(RRP): a reassessment of risks. Int J Pediatr Otorhinolaryngol 2005;69:1465-67.
23. de Bilderling G, Bodart E, Lawson BE, et al. Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis. J Med Virol 2005;75:332-5.
24. Morrison GA, Kotecha B, Evans JN, et al. Ribavarin treatment for juvenile respiratory papillomatosis. J Laryngol Otol 1993;107:423-6.
25. Endres DR, Bauman NM, Burke D, et al. Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study. Ann Otol Rhinol Laryngol 1994;103(4pt 1):301-5.
26. Rosen CA, Bryson PC. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 2004;18:248-53.
27. Pashley NR. Can mumps vaccine induce remission in recurrent respiratory papilloma? Arch Otolaryngol Head Neck Surg 2002;128:783-6.
28. Derkay CS, Smith RJH, McClay J, et al. HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial. Ann Otol Rhinol Laryngol 2005;114:730-7.
29. Harcourt JP, Worley G, Leighton SE, et al. Cimetidine treatment for recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 1999;51:109-13.
30. McKenna M, Brodsky L. Extraesophageal acid reflux and recurrent respiratory papilloma in children. Int J Pediatr Otorhinolaryngol 2005;69:597-605.
31. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadravalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.